{"id":21566,"date":"2026-04-13T09:37:44","date_gmt":"2026-04-13T02:37:44","guid":{"rendered":"https:\/\/www.nanovest.io/blog\/?p=21566"},"modified":"2026-04-13T09:37:44","modified_gmt":"2026-04-13T02:37:44","slug":"gsk-kembangkan-obat-kanker-baru-data-awal-menjanjikan","status":"publish","type":"post","link":"https:\/\/www.nanovest.io/blog\/saham-as\/gsk-kembangkan-obat-kanker-baru-data-awal-menjanjikan-21566\/","title":{"rendered":"GSK Kembangkan Obat Kanker Baru, Data Awal Menjanjikan"},"content":{"rendered":"<p><span style=\"font-weight: 400;\">Perusahaan farmasi global, <\/span><a href=\"https:\/\/nanovest.go.link\/page=IndividualStockDetail?action=navigate&amp;is_param=true&amp;symbol=GSK&amp;adj_t=1rhus2a1&amp;adj_deep_link=nanovest%3A%2F%2Fpage%3DIndividualStockDetail%3Faction%3Dnavigate%26is_param%3Dtrue%26symbol%3DGSK\"><span style=\"font-weight: 400;\">GlaxoSmithKline (GSK)<\/span><\/a><span style=\"font-weight: 400;\">, kembali menarik perhatian pasar setelah mengungkap data awal yang menjanjikan dari kandidat obat kanker terbarunya.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Terapi eksperimental bernama <\/span><b>Mo-rez<\/b><span style=\"font-weight: 400;\"> menunjukkan potensi signifikan dalam mengecilkan tumor pada pasien dengan kanker stadium lanjut, terutama pada jenis kanker yang selama ini sulit diobati.<\/span><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_86 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title\" style=\"cursor:inherit\">Daftar Isi <\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/www.nanovest.io/blog\/saham-as\/gsk-kembangkan-obat-kanker-baru-data-awal-menjanjikan-21566\/#Hasil_Awal_Tunjukkan_Respons_Tinggi_pada_Pasien\" >Hasil Awal Tunjukkan Respons Tinggi pada Pasien<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/www.nanovest.io/blog\/saham-as\/gsk-kembangkan-obat-kanker-baru-data-awal-menjanjikan-21566\/#Target_Spesifik_Jadi_Keunggulan_Utama\" >Target Spesifik Jadi Keunggulan Utama<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/www.nanovest.io/blog\/saham-as\/gsk-kembangkan-obat-kanker-baru-data-awal-menjanjikan-21566\/#GSK_Percepat_Pengembangan_di_Bawah_CEO_Baru\" >GSK Percepat Pengembangan di Bawah CEO Baru<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/www.nanovest.io/blog\/saham-as\/gsk-kembangkan-obat-kanker-baru-data-awal-menjanjikan-21566\/#Potensi_Besar_Tapi_Masih_Tahap_Awal\" >Potensi Besar, Tapi Masih Tahap Awal<\/a><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Hasil_Awal_Tunjukkan_Respons_Tinggi_pada_Pasien\"><\/span><b>Hasil Awal Tunjukkan Respons Tinggi pada Pasien<\/b><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><span style=\"font-weight: 400;\">Dalam uji coba tahap awal, Mo-rez berhasil menunjukkan tingkat respons yang cukup kuat.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Pada pasien dengan kanker ovarium yang resisten terhadap terapi platinum, sekitar <\/span><b>62%<\/b><span style=\"font-weight: 400;\"> mengalami penyusutan tumor setidaknya 30%. Sementara itu, pada kanker endometrium, angka respons bahkan mencapai <\/span><b>67%<\/b><span style=\"font-weight: 400;\">.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Hasil ini menjadi sinyal awal bahwa terapi tersebut berpotensi menjadi opsi baru di area yang selama ini memiliki keterbatasan pengobatan.<\/span><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Target_Spesifik_Jadi_Keunggulan_Utama\"><\/span><b>Target Spesifik Jadi Keunggulan Utama<\/b><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><span style=\"font-weight: 400;\">Mo-rez dikembangkan sebagai <\/span><b>antibody-drug conjugate (ADC)<\/b><span style=\"font-weight: 400;\"> \u2013 jenis terapi yang dirancang untuk menargetkan sel kanker secara lebih presisi.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Obat ini bekerja dengan mengincar protein <\/span><b>B7H4<\/b><span style=\"font-weight: 400;\">, yang banyak ditemukan pada sel kanker ginekologi namun relatif minim pada jaringan sehat.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Pendekatan ini diharapkan dapat meningkatkan efektivitas terapi sekaligus meminimalkan efek samping. Seiring meningkatnya minat terhadap terapi berbasis ADC, pasar global untuk segmen ini diproyeksikan mencapai US$31 miliar pada 2030.<\/span><\/p>\n<h2><span class=\"ez-toc-section\" id=\"GSK_Percepat_Pengembangan_di_Bawah_CEO_Baru\"><\/span><b>GSK Percepat Pengembangan di Bawah CEO Baru<\/b><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><span style=\"font-weight: 400;\">Data positif ini juga menjadi dorongan bagi strategi baru GSK di bawah kepemimpinan CEO Luke Miels, yang mulai menjabat awal tahun ini.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Perusahaan menegaskan akan mempercepat pengembangan pipeline obat, termasuk Mo-rez yang kini menjadi salah satu prioritas utama.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Saat ini, dua uji klinis tahap akhir sedang berjalan, serta tiga studi tambahan direncanakan dalam waktu dekat.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Langkah ini mencerminkan upaya GSK untuk memperkuat posisi di bisnis onkologi, yang semakin kompetitif dan bernilai tinggi.<\/span><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Potensi_Besar_Tapi_Masih_Tahap_Awal\"><\/span><b>Potensi Besar, Tapi Masih Tahap Awal<\/b><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><span style=\"font-weight: 400;\">Meski hasil awal terlihat menjanjikan, para analis masih belum memasukkan Mo-rez ke dalam proyeksi penjualan jangka panjang.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Hal ini wajar, mengingat data masih dalam tahap awal, uji klinis lanjutan masih berlangsung, dan persetujuan regulator belum diperoleh.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Namun, jika hasil konsisten di tahap berikutnya, obat ini berpotensi menjadi salah satu produk unggulan di masa depan.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Perkembangan ini menunjukkan satu tren yang semakin jelas: terapi kanker kini bergerak ke arah yang lebih presisi dan terpersonalisasi.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Dengan pendekatan yang lebih targeted, perusahaan farmasi berlomba menghadirkan terapi yang lebih efektif, lebih aman, dan memiliki nilai komersial tinggi.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Bagi investor, segmen onkologi \u2013 terutama teknologi seperti ADC \u2013 menjadi salah satu area yang terus dipantau.<\/span><\/p>\n<p>&nbsp;<\/p>\n<p><i><span style=\"font-weight: 400;\">Kalau kamu ingin mengikuti perkembangan sektor kesehatan global dan peluang investasinya, kamu bisa memantau berbagai aset <\/span><\/i><span style=\"font-weight: 400;\">\u2013 <\/span><i><span style=\"font-weight: 400;\">mulai dari saham AS hingga aset digital <\/span><\/i><span style=\"font-weight: 400;\">\u2013 <\/span><i><span style=\"font-weight: 400;\">langsung dalam satu aplikasi di <\/span><\/i><a href=\"https:\/\/www.nanovest.io\/\"><i><span style=\"font-weight: 400;\">Nanovest<\/span><\/i><\/a><i><span style=\"font-weight: 400;\">.<\/span><\/i><\/p>\n<p><i><span style=\"font-weight: 400;\">Dapatkan juga update pasar, insight terbaru, serta panduan investasi lainnya di halaman <\/span><\/i><a href=\"https:\/\/www.nanovest.io/blog\/\"><i><span style=\"font-weight: 400;\">News dan Artikel Tips Nanovest<\/span><\/i><\/a><i><span style=\"font-weight: 400;\"> untuk membantu kamu mengambil keputusan yang lebih tepat.<\/span><\/i><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Perusahaan farmasi global, GlaxoSmithKline (GSK), kembali menarik perhatian pasar setelah mengungkap data awal yang menjanjikan dari kandidat obat kanker terbarunya. Terapi eksperimental bernama Mo-rez menunjukkan potensi signifikan dalam mengecilkan tumor pada pasien dengan kanker stadium lanjut, terutama pada jenis kanker yang selama ini sulit diobati. Hasil Awal Tunjukkan Respons Tinggi pada Pasien Dalam uji coba<\/p>\n","protected":false},"author":35,"featured_media":21567,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[80,39],"tags":[],"class_list":["post-21566","post","type-post","status-publish","format-standard","has-post-thumbnail","category-berita","category-saham-as"],"acf":[],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO Pro 5.0.0.1 - aioseo.com -->\n\t<meta name=\"description\" content=\"GlaxoSmithKline (GSK) kembangkan obat kanker baru dengan hasil awal positif. Terapi targeted ini berpotensi jadi pemain besar di pasar onkologi global.\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<meta name=\"author\" content=\"Maretha Putri\"\/>\n\t<link rel=\"canonical\" href=\"https:\/\/www.nanovest.io/blog\/saham-as\/gsk-kembangkan-obat-kanker-baru-data-awal-menjanjikan-21566\/\" \/>\n\t<meta name=\"generator\" content=\"All in One SEO Pro (AIOSEO) 5.0.0.1\" \/>\n\t\t<meta property=\"og:locale\" content=\"id_ID\" \/>\n\t\t<meta property=\"og:site_name\" content=\"Blog Nanovest - Artikel dan Berita Kripto, Saham AS, dan Emas\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"GSK Kembangkan Obat Kanker Baru, Data Awal Menjanjikan\" \/>\n\t\t<meta property=\"og:description\" content=\"GlaxoSmithKline (GSK) kembangkan obat kanker baru dengan hasil awal positif. Terapi targeted ini berpotensi jadi pemain besar di pasar onkologi global.\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/www.nanovest.io/blog\/saham-as\/gsk-kembangkan-obat-kanker-baru-data-awal-menjanjikan-21566\/\" \/>\n\t\t<meta property=\"og:image\" content=\"https:\/\/www.nanovest.io/blog\/wp-content\/uploads\/2026\/04\/ChatGPT-Image-Apr-13-2026-09_35_30-AM-1.png\" \/>\n\t\t<meta property=\"og:image:secure_url\" content=\"https:\/\/www.nanovest.io/blog\/wp-content\/uploads\/2026\/04\/ChatGPT-Image-Apr-13-2026-09_35_30-AM-1.png\" \/>\n\t\t<meta property=\"og:image:width\" content=\"1536\" \/>\n\t\t<meta property=\"og:image:height\" content=\"1024\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2026-04-13T02:37:44+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2026-04-13T02:37:44+00:00\" \/>\n\t\t<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/nanovest\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n\t\t<meta name=\"twitter:site\" content=\"@nanovest_io\" \/>\n\t\t<meta name=\"twitter:title\" content=\"GSK Kembangkan Obat Kanker Baru, Data Awal Menjanjikan\" \/>\n\t\t<meta name=\"twitter:description\" content=\"GlaxoSmithKline (GSK) kembangkan obat kanker baru dengan hasil awal positif. Terapi targeted ini berpotensi jadi pemain besar di pasar onkologi global.\" \/>\n\t\t<meta name=\"twitter:creator\" content=\"@nanovest_io\" \/>\n\t\t<meta name=\"twitter:image\" content=\"https:\/\/www.nanovest.io/blog\/wp-content\/uploads\/2026\/04\/ChatGPT-Image-Apr-13-2026-09_35_30-AM-1.png\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/saham-as\\\/gsk-kembangkan-obat-kanker-baru-data-awal-menjanjikan-21566\\\/#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.nanovest.io/blog#listItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.nanovest.io/blog\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/category\\\/saham-as\\\/#listItem\",\"name\":\"Saham AS\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/category\\\/saham-as\\\/#listItem\",\"position\":2,\"name\":\"Saham AS\",\"item\":\"https:\\\/\\\/www.nanovest.io/blog\\\/category\\\/saham-as\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/saham-as\\\/gsk-kembangkan-obat-kanker-baru-data-awal-menjanjikan-21566\\\/#listItem\",\"name\":\"GSK Kembangkan Obat Kanker Baru, Data Awal Menjanjikan\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.nanovest.io/blog#listItem\",\"name\":\"Home\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/saham-as\\\/gsk-kembangkan-obat-kanker-baru-data-awal-menjanjikan-21566\\\/#listItem\",\"position\":3,\"name\":\"GSK Kembangkan Obat Kanker Baru, Data Awal Menjanjikan\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/category\\\/saham-as\\\/#listItem\",\"name\":\"Saham AS\"}}]},{\"@type\":\"NewsArticle\",\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/saham-as\\\/gsk-kembangkan-obat-kanker-baru-data-awal-menjanjikan-21566\\\/#newsarticle\",\"name\":\"GSK Kembangkan Obat Kanker Baru, Data Awal Menjanjikan\",\"headline\":\"GSK Kembangkan Obat Kanker Baru, Data Awal Menjanjikan\",\"author\":{\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/author\\\/maretha\\\/#author\"},\"publisher\":{\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/#organization\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/www.nanovest.io/blog\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/ChatGPT-Image-Apr-13-2026-09_35_30-AM-1.png\",\"width\":1536,\"height\":1024},\"datePublished\":\"2026-04-13T09:37:44+07:00\",\"dateModified\":\"2026-04-13T09:37:44+07:00\",\"inLanguage\":\"id-ID\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/saham-as\\\/gsk-kembangkan-obat-kanker-baru-data-awal-menjanjikan-21566\\\/#webpage\"},\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/saham-as\\\/gsk-kembangkan-obat-kanker-baru-data-awal-menjanjikan-21566\\\/#webpage\"},\"articleSection\":\"Berita, Saham AS\",\"dateline\":\"Published on April 13, 2026.\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/#organization\",\"name\":\"Nanovest\",\"description\":\"Artikel dan Berita Kripto, Saham AS, dan Emas\",\"url\":\"https:\\\/\\\/www.nanovest.io/blog\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/www.nanovest.io/blog\\\/wp-content\\\/uploads\\\/2023\\\/03\\\/site-logo-color.png\",\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/saham-as\\\/gsk-kembangkan-obat-kanker-baru-data-awal-menjanjikan-21566\\\/#organizationLogo\",\"width\":250,\"height\":250,\"caption\":\"site-logo-color\"},\"image\":{\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/saham-as\\\/gsk-kembangkan-obat-kanker-baru-data-awal-menjanjikan-21566\\\/#organizationLogo\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/nanovest\",\"https:\\\/\\\/twitter.com\\\/nanovest_io\",\"https:\\\/\\\/www.instagram.com\\\/nanovest.io\\\/\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UC5Y5fD2FApTWMc0c2mlxzIg\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/nano-vest\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/author\\\/maretha\\\/#author\",\"url\":\"https:\\\/\\\/www.nanovest.io/blog\\\/author\\\/maretha\\\/\",\"name\":\"Maretha Putri\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/saham-as\\\/gsk-kembangkan-obat-kanker-baru-data-awal-menjanjikan-21566\\\/#authorImage\",\"url\":\"https:\\\/\\\/www.nanovest.io/blog\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/cropped-ChatGPT-Image-Apr-6-2026-12_10_31-PM-96x96.png\",\"width\":96,\"height\":96,\"caption\":\"Maretha Putri\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/saham-as\\\/gsk-kembangkan-obat-kanker-baru-data-awal-menjanjikan-21566\\\/#webpage\",\"url\":\"https:\\\/\\\/www.nanovest.io/blog\\\/saham-as\\\/gsk-kembangkan-obat-kanker-baru-data-awal-menjanjikan-21566\\\/\",\"name\":\"GSK Kembangkan Obat Kanker Baru, Data Awal Menjanjikan\",\"description\":\"GlaxoSmithKline (GSK) kembangkan obat kanker baru dengan hasil awal positif. Terapi targeted ini berpotensi jadi pemain besar di pasar onkologi global.\",\"inLanguage\":\"id-ID\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/saham-as\\\/gsk-kembangkan-obat-kanker-baru-data-awal-menjanjikan-21566\\\/#breadcrumblist\"},\"author\":{\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/author\\\/maretha\\\/#author\"},\"creator\":{\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/author\\\/maretha\\\/#author\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/www.nanovest.io/blog\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/ChatGPT-Image-Apr-13-2026-09_35_30-AM-1.png\",\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/saham-as\\\/gsk-kembangkan-obat-kanker-baru-data-awal-menjanjikan-21566\\\/#mainImage\",\"width\":1536,\"height\":1024},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/saham-as\\\/gsk-kembangkan-obat-kanker-baru-data-awal-menjanjikan-21566\\\/#mainImage\"},\"datePublished\":\"2026-04-13T09:37:44+07:00\",\"dateModified\":\"2026-04-13T09:37:44+07:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/#website\",\"url\":\"https:\\\/\\\/www.nanovest.io/blog\\\/\",\"name\":\"Nanovest\",\"alternateName\":\"Blog Nanovest\",\"description\":\"Artikel dan Berita Kripto, Saham AS, dan Emas\",\"inLanguage\":\"id-ID\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO Pro -->\r\n\t\t<title>GSK Kembangkan Obat Kanker Baru, Data Awal Menjanjikan<\/title>\n\n","aioseo_head_json":{"title":"GSK Kembangkan Obat Kanker Baru, Data Awal Menjanjikan","description":"GlaxoSmithKline (GSK) kembangkan obat kanker baru dengan hasil awal positif. Terapi targeted ini berpotensi jadi pemain besar di pasar onkologi global.","canonical_url":"https:\/\/www.nanovest.io/blog\/saham-as\/gsk-kembangkan-obat-kanker-baru-data-awal-menjanjikan-21566\/","robots":"max-image-preview:large","keywords":"","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BreadcrumbList","@id":"https:\/\/www.nanovest.io/blog\/saham-as\/gsk-kembangkan-obat-kanker-baru-data-awal-menjanjikan-21566\/#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/www.nanovest.io/blog#listItem","position":1,"name":"Home","item":"https:\/\/www.nanovest.io/blog","nextItem":{"@type":"ListItem","@id":"https:\/\/www.nanovest.io/blog\/category\/saham-as\/#listItem","name":"Saham AS"}},{"@type":"ListItem","@id":"https:\/\/www.nanovest.io/blog\/category\/saham-as\/#listItem","position":2,"name":"Saham AS","item":"https:\/\/www.nanovest.io/blog\/category\/saham-as\/","nextItem":{"@type":"ListItem","@id":"https:\/\/www.nanovest.io/blog\/saham-as\/gsk-kembangkan-obat-kanker-baru-data-awal-menjanjikan-21566\/#listItem","name":"GSK Kembangkan Obat Kanker Baru, Data Awal Menjanjikan"},"previousItem":{"@type":"ListItem","@id":"https:\/\/www.nanovest.io/blog#listItem","name":"Home"}},{"@type":"ListItem","@id":"https:\/\/www.nanovest.io/blog\/saham-as\/gsk-kembangkan-obat-kanker-baru-data-awal-menjanjikan-21566\/#listItem","position":3,"name":"GSK Kembangkan Obat Kanker Baru, Data Awal Menjanjikan","previousItem":{"@type":"ListItem","@id":"https:\/\/www.nanovest.io/blog\/category\/saham-as\/#listItem","name":"Saham AS"}}]},{"@type":"NewsArticle","@id":"https:\/\/www.nanovest.io/blog\/saham-as\/gsk-kembangkan-obat-kanker-baru-data-awal-menjanjikan-21566\/#newsarticle","name":"GSK Kembangkan Obat Kanker Baru, Data Awal Menjanjikan","headline":"GSK Kembangkan Obat Kanker Baru, Data Awal Menjanjikan","author":{"@id":"https:\/\/www.nanovest.io/blog\/author\/maretha\/#author"},"publisher":{"@id":"https:\/\/www.nanovest.io/blog\/#organization"},"image":{"@type":"ImageObject","url":"https:\/\/www.nanovest.io/blog\/wp-content\/uploads\/2026\/04\/ChatGPT-Image-Apr-13-2026-09_35_30-AM-1.png","width":1536,"height":1024},"datePublished":"2026-04-13T09:37:44+07:00","dateModified":"2026-04-13T09:37:44+07:00","inLanguage":"id-ID","mainEntityOfPage":{"@id":"https:\/\/www.nanovest.io/blog\/saham-as\/gsk-kembangkan-obat-kanker-baru-data-awal-menjanjikan-21566\/#webpage"},"isPartOf":{"@id":"https:\/\/www.nanovest.io/blog\/saham-as\/gsk-kembangkan-obat-kanker-baru-data-awal-menjanjikan-21566\/#webpage"},"articleSection":"Berita, Saham AS","dateline":"Published on April 13, 2026."},{"@type":"Organization","@id":"https:\/\/www.nanovest.io/blog\/#organization","name":"Nanovest","description":"Artikel dan Berita Kripto, Saham AS, dan Emas","url":"https:\/\/www.nanovest.io/blog\/","logo":{"@type":"ImageObject","url":"https:\/\/www.nanovest.io/blog\/wp-content\/uploads\/2023\/03\/site-logo-color.png","@id":"https:\/\/www.nanovest.io/blog\/saham-as\/gsk-kembangkan-obat-kanker-baru-data-awal-menjanjikan-21566\/#organizationLogo","width":250,"height":250,"caption":"site-logo-color"},"image":{"@id":"https:\/\/www.nanovest.io/blog\/saham-as\/gsk-kembangkan-obat-kanker-baru-data-awal-menjanjikan-21566\/#organizationLogo"},"sameAs":["https:\/\/www.facebook.com\/nanovest","https:\/\/twitter.com\/nanovest_io","https:\/\/www.instagram.com\/nanovest.io\/","https:\/\/www.youtube.com\/channel\/UC5Y5fD2FApTWMc0c2mlxzIg","https:\/\/www.linkedin.com\/company\/nano-vest\/"]},{"@type":"Person","@id":"https:\/\/www.nanovest.io/blog\/author\/maretha\/#author","url":"https:\/\/www.nanovest.io/blog\/author\/maretha\/","name":"Maretha Putri","image":{"@type":"ImageObject","@id":"https:\/\/www.nanovest.io/blog\/saham-as\/gsk-kembangkan-obat-kanker-baru-data-awal-menjanjikan-21566\/#authorImage","url":"https:\/\/www.nanovest.io/blog\/wp-content\/uploads\/2026\/04\/cropped-ChatGPT-Image-Apr-6-2026-12_10_31-PM-96x96.png","width":96,"height":96,"caption":"Maretha Putri"}},{"@type":"WebPage","@id":"https:\/\/www.nanovest.io/blog\/saham-as\/gsk-kembangkan-obat-kanker-baru-data-awal-menjanjikan-21566\/#webpage","url":"https:\/\/www.nanovest.io/blog\/saham-as\/gsk-kembangkan-obat-kanker-baru-data-awal-menjanjikan-21566\/","name":"GSK Kembangkan Obat Kanker Baru, Data Awal Menjanjikan","description":"GlaxoSmithKline (GSK) kembangkan obat kanker baru dengan hasil awal positif. Terapi targeted ini berpotensi jadi pemain besar di pasar onkologi global.","inLanguage":"id-ID","isPartOf":{"@id":"https:\/\/www.nanovest.io/blog\/#website"},"breadcrumb":{"@id":"https:\/\/www.nanovest.io/blog\/saham-as\/gsk-kembangkan-obat-kanker-baru-data-awal-menjanjikan-21566\/#breadcrumblist"},"author":{"@id":"https:\/\/www.nanovest.io/blog\/author\/maretha\/#author"},"creator":{"@id":"https:\/\/www.nanovest.io/blog\/author\/maretha\/#author"},"image":{"@type":"ImageObject","url":"https:\/\/www.nanovest.io/blog\/wp-content\/uploads\/2026\/04\/ChatGPT-Image-Apr-13-2026-09_35_30-AM-1.png","@id":"https:\/\/www.nanovest.io/blog\/saham-as\/gsk-kembangkan-obat-kanker-baru-data-awal-menjanjikan-21566\/#mainImage","width":1536,"height":1024},"primaryImageOfPage":{"@id":"https:\/\/www.nanovest.io/blog\/saham-as\/gsk-kembangkan-obat-kanker-baru-data-awal-menjanjikan-21566\/#mainImage"},"datePublished":"2026-04-13T09:37:44+07:00","dateModified":"2026-04-13T09:37:44+07:00"},{"@type":"WebSite","@id":"https:\/\/www.nanovest.io/blog\/#website","url":"https:\/\/www.nanovest.io/blog\/","name":"Nanovest","alternateName":"Blog Nanovest","description":"Artikel dan Berita Kripto, Saham AS, dan Emas","inLanguage":"id-ID","publisher":{"@id":"https:\/\/www.nanovest.io/blog\/#organization"}}]},"og:locale":"id_ID","og:site_name":"Blog Nanovest - Artikel dan Berita Kripto, Saham AS, dan Emas","og:type":"article","og:title":"GSK Kembangkan Obat Kanker Baru, Data Awal Menjanjikan","og:description":"GlaxoSmithKline (GSK) kembangkan obat kanker baru dengan hasil awal positif. Terapi targeted ini berpotensi jadi pemain besar di pasar onkologi global.","og:url":"https:\/\/www.nanovest.io/blog\/saham-as\/gsk-kembangkan-obat-kanker-baru-data-awal-menjanjikan-21566\/","og:image":"https:\/\/www.nanovest.io/blog\/wp-content\/uploads\/2026\/04\/ChatGPT-Image-Apr-13-2026-09_35_30-AM-1.png","og:image:secure_url":"https:\/\/www.nanovest.io/blog\/wp-content\/uploads\/2026\/04\/ChatGPT-Image-Apr-13-2026-09_35_30-AM-1.png","og:image:width":1536,"og:image:height":1024,"article:published_time":"2026-04-13T02:37:44+00:00","article:modified_time":"2026-04-13T02:37:44+00:00","article:publisher":"https:\/\/www.facebook.com\/nanovest","twitter:card":"summary_large_image","twitter:site":"@nanovest_io","twitter:title":"GSK Kembangkan Obat Kanker Baru, Data Awal Menjanjikan","twitter:description":"GlaxoSmithKline (GSK) kembangkan obat kanker baru dengan hasil awal positif. Terapi targeted ini berpotensi jadi pemain besar di pasar onkologi global.","twitter:creator":"@nanovest_io","twitter:image":"https:\/\/www.nanovest.io/blog\/wp-content\/uploads\/2026\/04\/ChatGPT-Image-Apr-13-2026-09_35_30-AM-1.png"},"aioseo_meta_data":{"post_id":"21566","title":"#post_title","description":"GlaxoSmithKline (GSK) kembangkan obat kanker baru dengan hasil awal positif. Terapi targeted ini berpotensi jadi pemain besar di pasar onkologi global.","keywords":null,"keyphrases":{"focus":{"keyphrase":"","score":0,"analysis":{"keyphraseInTitle":{"score":0,"maxScore":9,"error":1}}},"additional":[]},"primary_term":null,"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"default","og_image_url":null,"og_image_width":null,"og_image_height":null,"og_image_custom_url":null,"og_image_custom_fields":null,"og_video":"","og_custom_url":null,"og_article_section":null,"og_article_tags":null,"twitter_use_og":true,"twitter_card":"default","twitter_image_type":"default","twitter_image_url":null,"twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_title":null,"twitter_description":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"NewsArticle","isEnabled":true},"graphs":[]},"schema_type":"default","schema_type_options":null,"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":"-1","robots_max_videopreview":"-1","robots_max_imagepreview":"large","priority":null,"frequency":"default","local_seo":null,"seo_analyzer_scan_date":"2026-04-13 03:37:00","breadcrumb_settings":null,"limit_modified_date":false,"reviewed_by":null,"open_ai":null,"ai":{"faqs":[],"keyPoints":[],"titles":[],"descriptions":[],"socialPosts":{"email":[],"linkedin":[],"twitter":[],"facebook":[],"instagram":[]}},"created":"2026-04-13 02:36:02","updated":"2026-04-13 03:37:01","focus_keyword":null,"additional_keywords":null,"truseo_locale":null},"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t<a href=\"https:\/\/www.nanovest.io/blog\" title=\"Home\">Home<\/a>\n<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\t<a href=\"https:\/\/www.nanovest.io/blog\/category\/saham-as\/\" title=\"Saham AS\">Saham AS<\/a>\n<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\tGSK Kembangkan Obat Kanker Baru, Data Awal Menjanjikan\n<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"Home","link":"https:\/\/www.nanovest.io/blog"},{"label":"Saham AS","link":"https:\/\/www.nanovest.io/blog\/category\/saham-as\/"},{"label":"GSK Kembangkan Obat Kanker Baru, Data Awal Menjanjikan","link":"https:\/\/www.nanovest.io/blog\/saham-as\/gsk-kembangkan-obat-kanker-baru-data-awal-menjanjikan-21566\/"}],"_links":{"self":[{"href":"https:\/\/www.nanovest.io/blog\/wp-json\/wp\/v2\/posts\/21566","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.nanovest.io/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.nanovest.io/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.nanovest.io/blog\/wp-json\/wp\/v2\/users\/35"}],"replies":[{"embeddable":true,"href":"https:\/\/www.nanovest.io/blog\/wp-json\/wp\/v2\/comments?post=21566"}],"version-history":[{"count":1,"href":"https:\/\/www.nanovest.io/blog\/wp-json\/wp\/v2\/posts\/21566\/revisions"}],"predecessor-version":[{"id":21568,"href":"https:\/\/www.nanovest.io/blog\/wp-json\/wp\/v2\/posts\/21566\/revisions\/21568"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.nanovest.io/blog\/wp-json\/wp\/v2\/media\/21567"}],"wp:attachment":[{"href":"https:\/\/www.nanovest.io/blog\/wp-json\/wp\/v2\/media?parent=21566"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.nanovest.io/blog\/wp-json\/wp\/v2\/categories?post=21566"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.nanovest.io/blog\/wp-json\/wp\/v2\/tags?post=21566"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}